The abstract discusses definitions of resistant hypertension but provides no quantitative data on the prevalence of white-coat hypertension in Spanish patients.
R esistant hypertension is a major public health challenge both in the United States and worldwide. Although various authors use different definitions, a recent scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research 1 defined resistant hypertension as blood pressure either controlled by 4 antihypertensive medications or 140/90 mm Hg, despite 3 antihypertensive medications of different classes, at near-maximal US Food and Drug Administration-approved doses, one of which is a diuretic. Some authors add a minimum duration of 3 months of such treatment; others insist that the medications must be "appropriately chosen," the patient adherent, and/or the patient referred by a physician to a hypertension center.
W.J. Elliott (Tue,) conducted a review in Resistant hypertension. The abstract discusses definitions of resistant hypertension but provides no quantitative data on the prevalence of white-coat hypertension in Spanish patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: